+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Assays - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806083
The global market for Stem Cell Assays was estimated at US$2.4 Billion in 2023 and is projected to reach US$7.7 Billion by 2030, growing at a CAGR of 17.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

How Are Stem Cell Assays Revolutionizing Drug Discovery and Development?

Stem cell assays have emerged as a crucial tool in the field of regenerative medicine, drug discovery, and development, offering insights into cellular behavior, differentiation, and potential therapeutic applications. These assays enable researchers to evaluate the potency, efficacy, and toxicity of drug candidates on stem cells, providing valuable data for preclinical studies. With the rising demand for personalized medicine and regenerative therapies, the use of stem cell assays is expanding rapidly in the pharmaceutical and biotechnology sectors. The ability of stem cell assays to model human diseases, predict drug responses, and screen for new therapeutic targets has made them indispensable for advancing next-generation treatments. Moreover, the adoption of stem cell assays in toxicity testing and high-throughput screening is driving their demand across research laboratories and contract research organizations (CROs).

What Technological Innovations Are Shaping the Future of Stem Cell Assays?

Technological advancements are significantly shaping the future of stem cell assays, enhancing their accuracy, reliability, and scalability. The integration of high-content screening (HCS), automated imaging, and data analytics is enabling the development of more sophisticated, robust, and reproducible stem cell assays. Innovations in 3D cell culture, organoids, and microfluidic systems are providing more physiologically relevant models that closely mimic in vivo conditions, improving the predictive power of stem cell assays. Additionally, the emergence of CRISPR-Cas9 gene editing technology and induced pluripotent stem cells (iPSCs) is expanding the scope of stem cell assays in studying genetic diseases, drug resistance, and cellular therapies. These innovations are driving the shift toward more efficient, high-throughput, and cost-effective assay platforms that can support the growing demand for precision medicine and targeted therapies.

Which Market Segments Are Leading the Growth of the Stem Cell Assays Industry?

Types of stem cell assays include viability/cytotoxicity assays, proliferation assays, differentiation assays, apoptosis assays, and others, with viability/cytotoxicity assays holding the largest market share due to their widespread use in drug toxicity testing and safety assessment. Applications of stem cell assays span drug discovery and development, regenerative medicine, clinical research, and toxicity testing, with drug discovery and development being a key segment due to the high demand for innovative and effective drug candidates. End-users of stem cell assays include pharmaceutical and biotechnology companies, academic and research institutes, and CROs, with pharmaceutical and biotechnology companies leading the market due to their significant investments in R&D and regenerative medicine. Geographically, North America, Europe, and Asia-Pacific are the largest markets for stem cell assays, driven by strong research infrastructure, government funding, and the growing focus on personalized medicine and cell-based therapies.

What Are the Key Drivers of Growth in the Stem Cell Assays Market?

The growth in the stem cell assays market is driven by several factors, including rising demand for regenerative medicine, personalized therapies, and targeted drug discovery, technological advancements in assay platforms, automation, and high-content screening, and the increasing adoption of stem cell assays in clinical trials, immunotherapy, and cancer research. The need to provide accurate, reproducible, and high-throughput solutions for various research and clinical applications is driving the demand for stem cell assays across multiple sectors. Technological innovations in 3D cell culture, organoids, gene editing, and data analytics, coupled with advancements in assay design, imaging, and multiplexing, are enhancing the performance, reliability, and marketability of stem cell assays, supporting market growth. The expansion of stem cell assay applications in neurobiology, cardiovascular research, infectious diseases, and toxicology, along with the growing emphasis on stem cell differentiation, characterization, and potency testing, is creating new opportunities for market players. Additionally, the focus on developing robust, cost-effective, and scalable stem cell assay solutions for diverse research needs is further propelling the growth of the stem cell assays market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Instruments Component segment, which is expected to reach US$6.1 Billion by 2030 with a CAGR of a 18.4%. The Kits Component segment is also set to grow at 17.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was valued at $661.0 Million in 2023, and China, forecasted to grow at an impressive 16.4% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Stem Cell Assays Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stem Cell Assays Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Stem Cell Assays Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Antria, Inc., Applied StemCell, Inc., Beike Biotechnology Co., Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 44 Featured):

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Stem Cell Assays - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Regenerative Medicine and Personalized Therapy Drives Adoption of Stem Cell Assays
  • Technological Advancements in High-Throughput Screening and Automation Propel Innovation in Stem Cell Assays
  • Increasing Use of Stem Cell Assays in Drug Discovery and Development Expands Addressable Market Opportunity
  • Focus on Predictive Toxicology and Disease Modeling Strengthens Business Case for Stem Cell Assays
  • Emergence of 3D Cell Culture and Organoid Models Enhances Applications of Stem Cell Assays
  • Rising Adoption of Stem Cell Assays in Clinical Trials, Immunotherapy, and Cancer Research Fuels Market Growth
  • Shift Toward High-Content Screening, Imaging, and Data Analytics Drives Market Adoption
  • Focus on Developing Robust, Reproducible, and Cost-Effective Stem Cell Assay Solutions Supports Market Competitiveness
  • Expansion of Stem Cell Assay Applications in Neurobiology, Cardiovascular, and Infectious Diseases Spurs Market Potential
  • Increasing Emphasis on Stem Cell Differentiation, Characterization, and Potency Testing Creates Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Stem Cell Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Viability / Cytotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Viability / Cytotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Differentiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Isolation & Purification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for Isolation & Purification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cell Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for Cell Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Proliferation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Proliferation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World 7-Year Perspective for Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World 7-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 24: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 25: World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for hESCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World 7-Year Perspective for hESCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 29: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 30: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 31: World 7-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 33: World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 34: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 35: USA 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 36: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 37: USA 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 38: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: USA 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 40: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 41: USA 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
CANADA
  • Table 42: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 43: Canada 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 44: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Canada 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 46: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: Canada 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 48: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: Canada 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
JAPAN
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 50: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Japan 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 52: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 53: Japan 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 54: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 55: Japan 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 56: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Japan 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
CHINA
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 58: China Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 59: China 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 60: China Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 61: China 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 62: China Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: China 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 64: China Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 65: China 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
EUROPE
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 66: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 67: Europe 7-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 68: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Europe 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 70: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 71: Europe 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 72: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 73: Europe 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 74: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Europe 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
FRANCE
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 76: France Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 77: France 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 78: France Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 79: France 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 80: France Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: France 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 82: France Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 83: France 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
GERMANY
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 84: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 85: Germany 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 86: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Germany 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 88: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 89: Germany 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 90: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 91: Germany 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
ITALY
  • Table 92: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Italy 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 94: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 95: Italy 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 96: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 97: Italy 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 98: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Italy 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
UNITED KINGDOM
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 100: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 101: UK 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 102: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 103: UK 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 104: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 105: UK 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 106: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 107: UK 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
REST OF EUROPE
  • Table 108: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 109: Rest of Europe 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 110: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 111: Rest of Europe 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 112: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 113: Rest of Europe 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 114: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 115: Rest of Europe 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
ASIA-PACIFIC
  • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 116: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 117: Asia-Pacific 7-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2024 & 2030
  • Table 118: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 119: Asia-Pacific 7-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2024 & 2030
  • Table 120: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 121: Asia-Pacific 7-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2024 & 2030
  • Table 122: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 123: Asia-Pacific 7-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2024 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

Table Information